250 related articles for article (PubMed ID: 15026321)
21. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis.
Samson M; Peale FV; Frantz G; Rioux-Leclercq N; Rajpert-De Meyts E; Ferrara N
J Clin Endocrinol Metab; 2004 Aug; 89(8):4078-88. PubMed ID: 15292351
[TBL] [Abstract][Full Text] [Related]
22. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.
Hoffmann P; Feige JJ; Alfaidy N
Endocrinology; 2006 Apr; 147(4):1675-84. PubMed ID: 16384869
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.
Mori A; Arii S; Furutani M; Hanaki K; Takeda Y; Moriga T; Kondo Y; Gorrin Rivas MJ; Imamura M
Int J Cancer; 1999 Mar; 80(5):738-43. PubMed ID: 10048976
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis.
Valcárcel M; Arteta B; Jaureguibeitia A; Lopategi A; Martínez I; Mendoza L; Muruzabal FJ; Salado C; Vidal-Vanaclocha F
J Transl Med; 2008 Oct; 6():57. PubMed ID: 18844982
[TBL] [Abstract][Full Text] [Related]
26. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
27. EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype, and function.
Lecouter J; Lin R; Ferrara N
Ann N Y Acad Sci; 2004 Apr; 1014():50-7. PubMed ID: 15153419
[TBL] [Abstract][Full Text] [Related]
28. Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma.
Ngan ES; Lee KY; Yeung WS; Ngan HY; Ng EH; Ho PC
Endocrinology; 2006 Jan; 147(1):88-95. PubMed ID: 16210375
[TBL] [Abstract][Full Text] [Related]
29. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression.
Yang C; Zhang JJ; Zhang XP; Xiao R; Li PG
World J Gastroenterol; 2019 Jul; 25(25):3196-3206. PubMed ID: 31333311
[TBL] [Abstract][Full Text] [Related]
30. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.
Chung JY; Song Y; Wang Y; Magness RR; Zheng J
J Clin Endocrinol Metab; 2004 May; 89(5):2484-90. PubMed ID: 15126581
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
34. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
[TBL] [Abstract][Full Text] [Related]
35. EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors.
Ferrara N; LeCouter J; Lin R; Peale F
Biochim Biophys Acta; 2004 Mar; 1654(1):69-78. PubMed ID: 14984768
[TBL] [Abstract][Full Text] [Related]
36. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
[TBL] [Abstract][Full Text] [Related]
37. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.
Okada F; Rak JW; Croix BS; Lieubeau B; Kaya M; Roncari L; Shirasawa S; Sasazuki T; Kerbel RS
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3609-14. PubMed ID: 9520413
[TBL] [Abstract][Full Text] [Related]
38. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
[TBL] [Abstract][Full Text] [Related]
39. Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.
Kurebayashi H; Goi T; Shimada M; Tagai N; Naruse T; Nakazawa T; Kimura Y; Hirono Y; Yamaguchi A
Oncotarget; 2015 Sep; 6(28):26242-51. PubMed ID: 26317645
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
